Package 65862-207-05

{"route": ["ORAL"], "spl_id": "683ccd3f-445b-4488-b14c-8d5810d8633a", "openfda": {"nui": ["N0000175459", "N0000175466"], "unii": ["49717AWG6K"], "rxcui": ["248109"], "spl_set_id": ["eee304d0-c2ea-44f4-97d9-92a414d31b6c"], "pharm_class_epc": ["Nucleoside Analog Antiviral [EPC]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (65862-207-05)", "package_ndc": "65862-207-05", "marketing_start_date": "20090917"}, {"sample": false, "description": "168 TABLET, FILM COATED in 1 BOTTLE (65862-207-68)", "package_ndc": "65862-207-68", "marketing_start_date": "20090917"}], "brand_name": "Ribavirin", "product_id": "65862-207_683ccd3f-445b-4488-b14c-8d5810d8633a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "65862-207", "generic_name": "Ribavirin", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ribavirin", "active_ingredients": [{"name": "RIBAVIRIN", "strength": "200 mg/1"}], "application_number": "ANDA079111", "marketing_category": "ANDA", "marketing_start_date": "20090917", "listing_expiration_date": "20261231"}